U.S. Life Sciences Stock News

Sportradar Group AG recently reported full-year 2025 results showing sales of €1,289.97 million and net income of €100.32 million, alongside issuing 2026 revenue guidance, completing a €171 million share buyback, and recording a small goodwill and intangibles impairment. A key development was FIFA’s decision to extend and expand its AI-driven integrity services agreement with Sportradar through 2031, deepening the company’s role in safeguarding global football competitions across FIFA and...

Madrigal Pharmaceuticals reported strong fourth quarter revenue, supported by demand for its new MASH therapy, Rezdiffra. Rezdiffra adoption is gaining traction in the commercial rollout, contributing to revenue that surpassed earlier expectations. Analysts have responded positively to the results, reflecting increased confidence in Madrigal’s commercial path for NasdaqGS:MDGL. Madrigal Pharmaceuticals, trading as NasdaqGS:MDGL, is drawing fresh attention after upbeat fourth quarter results...

LPL Financial Holdings and Simplicity Group previously announced a partnership under which, from May 1, 2026, Simplicity will become LPL’s preferred Brokerage General Agency, integrating LPL’s internal insurance unit and expanding advisors’ access to advanced insurance technology, planning support, and protection solutions. At the same time, LPL’s strong but expectation-missing quarterly results, evolving regulatory backdrop, and continued advisor recruiting underscore how business execution...

EchoStar (SATS) just posted full year 2025 results that combined a wider net loss with revenue slightly ahead of expectations, as heavy non cash impairments and restructuring costs hit the bottom line. See our latest analysis for EchoStar. Despite the heavier full year loss, EchoStar’s shares have been volatile rather than weak, with a 57.91% 90 day share price return and a very large 1 year total shareholder return. This reflects how investors have reacted to the planned spectrum sale to...

Ivanhoe Electric Inc. has reported its full-year 2025 results, with sales rising to US$3.24 million from US$2.90 million and the net loss narrowing to US$105.87 million from US$128.62 million, compared with 2024. The reduction in basic loss per share from continuing operations, to US$0.79 from US$1.07, points to improving cost and earnings efficiency even as the business remains loss-making. Next, we will examine how Ivanhoe Electric’s improved revenue and narrower net loss shape the...

In recent days, Mercury Systems, a U.S.-based aerospace and defense technology company, saw increased investor attention as escalating tensions in West Asia drew focus to defense suppliers supporting advanced military capabilities. This development underscores how shifts in regional security risk can quickly spotlight companies providing embedded processing, electronic warfare, and sensor technologies that underpin modern defense systems. We’ll now examine how this heightened focus on...

If you are wondering whether Voya Financial's current share price reflects its true worth, this article will walk through the key numbers that matter for valuation. The stock last closed at US$67.61, with returns of 3.0% decline over 7 days, 11.8% decline over 30 days, 10.6% decline year to date, 0.2% decline over 1 year, 1.9% decline over 3 years, and 16.9% gain over 5 years, which gives you a mixed picture of recent and longer term performance. This piece was prompted to provide ongoing...

Texas Capital Bancshares (TCBI) is back on investors’ radar after JPMorgan Chase & Co. and Quantbot Technologies LP increased their stakes. This comes alongside the bank’s completion of a $400 million fixed income offering. See our latest analysis for Texas Capital Bancshares. Despite some recent softness, with a 1 month share price return showing a 5.57% decline from a last close of US$95.53, Texas Capital Bancshares still carries a 1 year total shareholder return of 27.85%. This points to...

Adaptive Biotechnologies (ADPT) shares are back in focus after CEO Chad Robins outlined fresh expectations for MRD testing volumes and profitability, updating investors on growth initiatives and margin targets for the coming years. See our latest analysis for Adaptive Biotechnologies. At a share price of US$16.08, Adaptive Biotechnologies has seen a 13.1% 30 day share price decline and a 6.1% 90 day share price decline. However, its 1 year total shareholder return of 98% and 3 year total...

BRC (BRCC) has wrapped up FY 2025 with Q4 revenue of US$112.7 million, alongside a basic EPS loss of US$0.03 and a net income loss of US$3.2 million, setting a clear snapshot of where the business stands today. The company has seen quarterly revenue move from US$89.9 million in Q1 2025 to US$112.7 million in Q4 2025, while basic EPS has ranged from a loss of US$0.07 in Q2 2025 to a smaller loss of US$0.00 in Q3 2025. This gives investors a fuller view of how the top line and per share results...

ICF International stock: earnings miss, federal headwinds and a mixed near-term picture ICF International (ICFI) shares are back in focus after fourth quarter 2025 results came in below consensus on both earnings and revenue, as ongoing federal sector headwinds outweighed strength in commercial and non federal work. See our latest analysis for ICF International. The earnings miss and softer federal revenue backdrop appear to be weighing on sentiment. A 16.84% 1 month share price return...

Why Consolidated Edison raised fresh equity Consolidated Edison (ED) has just completed a follow on equity offering, issuing 7,000,000 new common shares for total proceeds of about $775.67 million at a price of $110.81 per share. See our latest analysis for Consolidated Edison. At a share price of $112.36, Consolidated Edison has recently recorded a 5.37% 1 month share price return and a 16.50% 3 month share price return, while its 5 year total shareholder return of 92.28% reflects a strong...

Why Hubbell (HUBB) Is On Investors’ Radar Today Hubbell (HUBB) is drawing attention after recent share price moves, with the stock showing mixed short term returns alongside stronger performance over the past 3 years and 5 years. See our latest analysis for Hubbell. At a latest share price of $488.49, Hubbell has pulled back with a 1-day share price return of a 5.51% decline and a 7-day share price return of a 7.26% decline, while its 1-year total shareholder return of 40.58% and 5-year total...

Semrush Holdings (SEMR) just posted its FY 2025 numbers with Q4 revenue of US$117.7 million and a basic EPS loss of US$0.07, alongside a full year trailing revenue line of US$443.6 million and a trailing basic EPS loss of US$0.13. Over recent periods the company has seen quarterly revenue move from US$97.4 million in Q3 FY 2024 to US$117.7 million in Q4 FY 2025. Basic EPS has shifted from a profit of US$0.02 in Q4 FY 2024 to a loss of US$0.07 in Q4 FY 2025, which highlights a situation where...

In late February 2026, BioMarin Pharmaceutical received U.S. FDA approval for a supplemental Biologics License Application expanding PALYNZIQ’s use to pediatric phenylketonuria patients aged 12 and older, following Phase 3 PEGASUS data and under a REMS program due to immune-mediated safety risks including anaphylaxis. This label expansion meaningfully broadens PALYNZIQ’s treated population, underscoring BioMarin’s ability to convert late-stage rare disease programs into commercial assets...

The RealReal (NasdaqGS:REAL) has reopened its reimagined San Francisco flagship store. The refreshed location expands physical retail services and emphasizes community focused offerings. The move highlights the company’s continued connection to its founding city and support for the local luxury shopping corridor. The RealReal, a luxury resale platform, is putting fresh weight behind brick and mortar with its updated San Francisco flagship. For a business built around authenticated...

Mobile Infrastructure (BEEP) FY 2025 Earnings Snapshot Mobile Infrastructure (BEEP) has wrapped up FY 2025 with Q4 total revenue of US$8.8 million and a basic EPS loss of US$0.19, alongside a net income loss of US$7.7 million, putting margins firmly in the red for the period. The company has seen quarterly revenue move between US$8.2 million and US$9.1 million over FY 2025, while basic EPS losses ranged from US$0.10 to US$0.19. Trailing twelve month figures show revenue of US$35.1 million...

In early March 2026, Amazon Web Services confirmed that drones struck three of its data centers in the UAE and Bahrain, causing structural damage, fires, water damage from fire suppression, and prolonged power and connectivity outages across parts of its Middle East cloud regions. This is the first time a major U.S. cloud provider’s data center infrastructure has been directly hit in a military conflict, spotlighting physical security and geographic risk as material considerations for...

Quanterix FY 2025 earnings snapshot Quanterix (QTRX) has reported fourth quarter FY 2025 revenue of US$43.9 million with a basic EPS loss of US$0.49, alongside trailing twelve month revenue of US$138.9 million and a basic EPS loss of US$2.51, setting a clear picture of scale and ongoing losses for investors watching the story. The company has seen quarterly revenue move from US$35.2 million in Q4 2024 to US$43.9 million in Q4 2025, while basic EPS losses widened from US$0.30 to US$0.49, so...

In February 2026, Hub Group, Inc. disclosed a US$77.0 million accounting error tied to purchased transportation costs and accounts payable, leading to plans to restate several 2025 quarterly results and delay its Form 10-K filing with the SEC. Shortly after revealing the error, the company’s board still affirmed a quarterly cash dividend of US$0.125 per share as part of its previously announced US$0.50 per-share annual capital allocation program, underscoring management’s commitment to...

Investor focus on Nutanix (NTNX) has intensified after the company paired a multi‑year AI infrastructure partnership and equity deal with AMD with fresh quarterly results showing higher revenue and net income versus the prior year. See our latest analysis for Nutanix. The AMD equity deal at a purchase price of US$36.26 now sits below the latest share price of US$40.70, after a 7 day share price return of 7.5% and a 90 day share price return decline of 14.23%. The 1 year total shareholder...

Apartment Investment and Management (AIV) has posted its latest FY 2025 numbers with third quarter revenue at US$35.1 million and basic EPS at a US$0.71 loss, while trailing twelve month figures show revenue of US$210.9 million and basic EPS of a US$1.01 loss. Over the past few reported periods, revenue has moved between US$35.1 million and US$54.2 million a quarter, with basic EPS ranging from a loss of US$0.07 to a loss of US$1.07, giving investors a clear view of the pressure on margins...

Village Super Market (VLGE.A) has reported another steady quarter, with Q2 2026 revenue of US$582.6 million and basic EPS of US$0.81 setting the tone for its latest update. The company has seen revenue hold in a tight band between US$557.7 million and US$599.7 million across the last five reported quarters, while quarterly EPS has moved between US$0.75 and US$1.14. Trailing twelve month EPS sits at US$3.75, giving investors a view of consistent top line scale and earnings power as they assess...

NewAmsterdam Pharma recently reported full-year 2025 results showing sales of US$22.5 million and a narrower net loss of US$203.82 million, while also filing a shelf registration to offer up to 5,719,966 common shares and confirming multiple March 2026 investor conference appearances. Shortly after these disclosures, CEO Michael H. Davidson sold 443,707 ordinary shares for roughly US$14.75 million, a sizable insider transaction that may shape investor perceptions of management’s confidence...